TickerFacts.

Aclarion, Inc. (ACON): Gross Profit

Annual figures by period end, from SEC filings.

$6.8K
Year ended 2025-12-31
$18.2K
Trailing 12 months to 2026-06-30
2021-12-31: -$8.9K2022-12-31: -$4.9K2023-12-31: -$3242024-12-31: -$38.9K2025-12-31: $6.8K$6.8K
2021-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$6.8Kn/m2026-03-18, From 2025-01-01
2024-12-31-$38.9Kn/m2026-03-18, From 2024-01-01
2023-12-31-$324n/m2025-04-09, From 2023-01-01
2022-12-31-$4.9Kn/m2024-03-28, From 2022-01-01
2021-12-31-$8.9Kn/a2023-06-12, From 2021-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Aclarion, Inc. (ACON)2025-12-31$6.8Kn/m
Sera Prognostics, Inc. (SERA)2025-12-31-$83.0Kn/m
YD Bio Ltd (YDES)2025-12-31$167.4K+7.8%
BioNexus Gene Lab Corp (BGLC)2025-12-31$1.09M-15.8%
American Shared Hospital Services (AMS)2025-12-31$5.06M-44.9%
Exagen Inc. (XGN)2025-12-31$38.80M+17.2%
Personalis, Inc. (PSNL)2025-12-31$15.78M-41.2%
BillionToOne, Inc. (BLLN)2025-12-31$208.46M+157.6%
Fulgent Genetics, Inc. (FLGT)2025-12-31$130.88M+22.1%

Compare ACON, SERA, YDES, BGLC side by side · Screen every company in Services-Medical Laboratories ↗